Mark A. Velleca - Aug 9, 2021 Form 4 Insider Report for Black Diamond Therapeutics, Inc. (BDTX)

Role
Director
Signature
/s/ Brent Hatzis-Schoch, Attorney-in-Fact
Stock symbol
BDTX
Transactions as of
Aug 9, 2021
Transactions value $
$0
Form type
4
Date filed
8/11/2021, 04:58 PM
Previous filing
Jul 15, 2021
Next filing
Nov 10, 2021

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BDTX Stock Option (Right to Buy) Award $0 +30K $0.00 30K Aug 9, 2021 Common Stock 30K $9.85 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This option shall vest and become exercisable in thirty-six (36) equal monthly installments following the Grant Date.